Epidemiology of Neonatal Sepsis in Neonatal Intensive Care Unit in Assiut University Children Hospital
NCT03354650 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-12-05
Summary
Neonatal sepsis is an important cause of morbidity and mortality in the pediatric age group . It is one of the leading causes of death in the first 28 days of life both in the developed and developing countries.
Conditions
- Neonatal SEPSIS
Interventions
- DIAGNOSTIC_TEST
-
blood culture
blood culture to determine causative organisms of neonatal sepsis
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Gehan Mo Kamal El_Din, Professor · Assiut University
Eligibility
- Max Age
- 4 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2019-01-01
- Completion
- 2019-07-01
More Related Trials
-
Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis
NCT05742477 ·Status: UNKNOWN
-
Prognostic Value of Complete Blood Count in Severe Infections
NCT03685071 ·Status: UNKNOWN
-
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226 ·Status: RECRUITING
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
NeoAMR Observational Study in Neonatal Sepsis
NCT03721302 ·Status: COMPLETED
-
Early-Onset Sepsis an NICHD/CDC Surveillance Study
NCT02410486 ·Status: COMPLETED
-
Life After Pediatric Sepsis Evaluation
NCT01415180 ·Status: COMPLETED
-
Neonatal Sepsis, Evaluation, Bangladesh
NCT01333982 ·Status: COMPLETED ·Phase: NA
-
Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis
NCT06633770 ·Status: NOT_YET_RECRUITING
-
Performance of Interleukin-27 Cord Blood Level as A Biomarker Predicating Early Onset Neonatal Sepsis
NCT05589909 ·Status: UNKNOWN
-
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
NCT03280147 ·Status: COMPLETED ·Phase: PHASE3
-
Early Identification of Sepsis in Children
NCT03884595 ·Status: UNKNOWN
-
Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates
NCT03299751 ·Status: COMPLETED ·Phase: NA
-
Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
NCT03217721 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of Ceftazidime in Pediatric ICU Patients
NCT03133910 ·Status: UNKNOWN
-
Objective Sepsis Identification Tool to Study Sepsis Epidemiology
NCT04114214 ·Status: COMPLETED
-
Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator
NCT06643052 ·Status: NOT_YET_RECRUITING
-
Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)
NCT02567305 ·Status: UNKNOWN
-
Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children
NCT03441126 ·Status: COMPLETED
-
Impact of Low Dose Ketamine Infusion in Septic Patient on Non-invasive Estimators of ICP
NCT05149586 ·Status: COMPLETED
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
Epidemiological Investigation of Sepsis in Obstetrics Admitted to ICU
NCT05055388 ·Status: UNKNOWN
-
Epidemiology, Acute Management, and Outcomes of Patients With Sepsis Presenting to a Referral Hospital in Western Kenya
NCT02346331 ·Status: COMPLETED ·Phase: NA
-
Early Prediction of Sepsis by Using Metabolomics
NCT03996759 ·Status: UNKNOWN
-
Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database
NCT02281890 ·Status: COMPLETED